Navigation Links
Isis Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference
Date:7/5/2012

CARLSBAD, Calif., July 5, 2012 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at the 7th Annual JMP Securities Healthcare Conference on Thursday, July 12, 2012 at 2:00 p.m. ET at the Peninsula Hotel in New York.

A live audio webcast of the presentation will be available on the "Investors & Media" section of the Company's Web site, www.isispharm.com.  A replay of the presentation will be available on the Isis Web site within 48 hours and will be archived for a limited time.

ABOUT ISIS PHARMACEUTICALS, INC. Isis is exploiting its leadership position in antisense technology to discover and develop novel drugs for its product pipeline and for its partners.  Isis' broad pipeline consists of 25 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe and rare diseases, and cancer.  Isis' partner, Genzyme, plans to commercialize Isis' lead product, KYNAMRO, following regulatory approval, which is expected in 2012.  Isis' patents provide strong and extensive protection for its drugs and technology.  Additional information about Isis is available at www.isispharm.com.


'/>"/>
SOURCE Isis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Law Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.
2. The Leukemia & Lymphoma Society and Celator Pharmaceuticals Announce $5 Million Partnership to Support Phase 3 Development of CPX-351 for AML
3. Amylin Pharmaceuticals, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Bristol-Myers Squibb Company
4. Nouveau Life Pharmaceuticals (NOUV) In Talks with International Mass Distribution Firms
5. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.
6. Questcor Pharmaceuticals to Present at JMP Securities Healthcare Conference
7. Access Pharmaceuticals Announces Positive Data From MuGard Phase 4 Clinical Trial In Oral Mucositis At MASCC/ISOO 2012 Symposium
8. Pharmaceuticals: Global Industry Almanac, MarketLine
9. Prodigy Health Supplier Partners with Stason Pharmaceuticals to Help Relieve U.S. Drug Shortages
10. Nouveau Life Pharmaceuticals (NOUV) to Launch Affiliate Sales Program
11. Trading Of Onyx Pharmaceuticals Common Stock Halted
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... 2016  Zimmer Biomet Holdings, Inc. (NYSE and ... to its previously-announced cash tender offers (the "Offers") ... below (collectively, the "Notes"), approximately $2.6 billion in aggregate ... not validly withdrawn on or prior to 5:00 p.m., ... today, December 5, 2016 (the "Early Tender Deadline"). ...
(Date:12/5/2016)... , Dec. 5, 2016 France Glaucoma Surgery ... new report, "France Glaucoma Surgery Devices Market Outlook to ... Surgery Devices market. The report provides value, in millions ... (USD) within market segements - Canaloplasty Micro Catheters and ... shares and distribution shares data for each of these ...
(Date:12/5/2016)... , Dec. 5, 2016   Mallinckrodt Pharmaceuticals ... specialty pharmaceutical company, today announced that it received a ... Equality Index (CEI), a national benchmarking survey and report ... bisexual and transgender (LGBT) workplace equality, administered by the ... of 517 major U.S. businesses which also earned top ...
Breaking Medicine Technology:
(Date:12/5/2016)... , ... December 05, 2016 , ... The new knee ... individual looking to buy neoprene knee sleeves for lifting and any sport ... focuses heavily on two main aspects to provide a higher quality knee sleeve performance. ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... Rejuvenation" at the 2016 Anti-Aging & Beauty Awards at The Aesthetic & ... & Anti-aging Medicine European Congress (AMEC) brings together the industry’s leading scientific ...
(Date:12/4/2016)... ... December 02, 2016 , ... Metabolic Code (MC) and Power2Practice ... help doctors more efficiently manage their practice. Power2Practice is adding MC’s nutraceutical ... Integrative and Functional Medicine. , The Metabolic Code platform provides a leading-edge ...
(Date:12/4/2016)... ... ... While James Earl Jones is known for myriad roles on stage and screen, he ... of the forthcoming episodes examines mammogram techniques; a very important part of preventative medicine. ... early detection. Like any other disease, treatments have a much higher chance of success ...
(Date:12/4/2016)... ... December 04, 2016 , ... ... new attractive animation styles with unique displacement design elements," said Christina Austin - ... third designs. Choose from a variety of design styles that include both left ...
Breaking Medicine News(10 mins):